Abstract
Ischemia/reperfusion (I/R) injury is a major cause of morbidity and mortality in liver surgery and transplantation, and fatty livers are susceptible to greater I/R injury and a higher incidence of primary graft nonfunction after transplantation. Because alcohol intake and obesity are major causes of fatty liver, this study was initiated to investigate the effect of chronic ethanol consumption on hepatic microsomal cytochrome P450 (CYP) activity after I/R. Rats were fed an alcohol liquid diet or a control isocaloric diet for 4 weeks, and then subjected to 60 min of hepatic ischemia and 5 h of reperfusion. It was found that, chronic ethanol consumption significantly increased liver weight, serum triglyceride (TG), liver TG, and serum aminotransferase activities. Moreover, alcoholic fatty livers exposed to I/R showed significantly higher levels of aminotransferase activities than the controls. No significant differences in microsomal CYP content or CYP1A1 activity were found between I/R treated animals fed a control diet (the CD + I/R group) and I/R treated animals fed an ethanol containing diet (the ED + I/R group). Moreover, whereas CYP1A2 activity was decreased in the ED + I/R group versus the CD + I/R group, CYP2E1 activity was elevated. Additionally, chronic alcohol consumption up-regulatedTNF- α andIL- 6 mRNA levels immediately after I/R. In conclusion, chronic ethanol consumption was found to potentiate hepatocellular damage as indicated by abnormalities in microsomal drug metabolizing function during I/R.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Belghiti, J., Hiramatsu, K., Benoist, S., Massault, P., Sauvanet, A., and Farges, O., Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection.J. Am. Coll. Surg., 191, 38–46 (2000).
Bradford, M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal. Biochem., 72, 248–254 (1976).
Buege, T. A. and Aust, S. D., Microsomal lipid peroxidation.Methods Enzymol., 52, 302–310 (1978).
Burke, M. D., Thompson, S., Elcombe, C. R., Halpert, J., Haparanta, T., and Mayer, R. T., Ethoxy-, pentoxy-, and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P450.Biochem. Biopharmacol., 34, 3337–3345 (1985).
Chomczynski, P. and Sacchi, N., Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.Anal. Biochem., 162, 156–159 (1987).
de la M Hall, P., Lieber, C. S., CeCarli, L. M., French, S. W., Lindros, K. O., Jarvelainen, H., Bode, C, Parlesak, A., and Bode, J. C, Models of alcoholic liver disease in rodents: a critical evaluation.Alcohol Clin. Exp. Res., 25, 245S-261S (2001).
Eum, H. A. and Lee, S. M., Effects of Trolox on the activity and gene expression of cytochrome P450 in hepatic ischemia/ reperfusion.Br. J. Pharmacol., 142, 35–42 (2004).
Falck-Ytter, Y., Younossi, Z. M., Marchesini, G., and McCullough, A. J., Clinical features and natural history of nonalcoholic steatosis syndrome.Semin. Liver Dis., 21, 17–26 (2001).
Folch, J., Lees, M., and Sloane Stanley, G. H., A simple method for the isolation and purification of total lipids from animal tissue.J. Biol. Chem., 226, 497–509 (1957).
Guengerich, F. P., Dannan, G. A., Wright, S. T., Martin, M. V., and Kaminsky, L. S., Purification and characterization of microsomal cytochrome P-450s.Xenobiotica, 12, 701–716 (1982).
Hill, D. B., Barve, S., Joshi-Barve, S., and McClain, C, Increased monocyte nuclear factor-kappaB activation and tumor necrosis factor production in alcoholic hepatitis.J. Lab. Clin. Med., 135, 387–395 (2000).
Hong, J. Y., Pan, J. M., Gonzalez, F. J., Gelboin, H. V., and Yang, C. S., The induction of a specific form of P-450 (P- 450j) by fasting.Biochem. Biophys. Res. Commun., 142, 1077–1083 (1987).
Huet, P. M. and Villenueve, J. P., Determinants of drug disposition in patients with cirrhosis.Hepatology, 3, 913–918 (1983).
Jones, D. P., Aw, T. Y, and Shan, X. Q., Drug metabolism and toxicity during hypoxia.Drug Metab. Rev., 20, 247–249 (1989).
Karaa, A., Kamoun, W. S., and Clemens, M. G, Chronic ethanol sensitizes the liver to endotoxin via effects on endothelial nitric oxide synthase regulation.Shock, 24, 447- 454 (2005).
Kerai, M. D. J., Waterfield, C. J., Kenyon, S. H., Asker, D. S., and Timbrell, J. A., Taurine: protective properties against ethanol- induced hepatic steatosis and lipid peroxidation during chronic ethanol consumption in rats.Amino Acid, 15, 53–76 (1998).
Lee, S. M., Park, M. J., Cho, T. S., and Clemens, M. G., Hepatic injury and lipid peroxidation during ischemia and reperfusion.Shock, 13, 279–284 (2000).
Lieber, C. S., Microsomal ethanol-oxidizing system (MEOS): The first 30 years (1968–1998)-a review.Alcoholism Clin. Exp. Res., 23, 991–1007 (1999).
Lieber, C. S. and DeCarli, L. M., Liquid diet technique of ethanol administration: 1989 update.Alcohol Alcohol., 24, 197–211 (1989).
Lieber, C. S., Lasker, J. M., DeCarli, L. M., Saeli, J., and Wojtowicz, T, Role of acetone, dietary fat and total energy intake in induction of hepatic microsomal ethanol oxidizing system.J. Pharmacol. Exp. Ther., 1247, 791–795 (1988).
McClain, C. J., Barve, S., Deaciuc, I., Kugelmas, M., and Hill, D., Cytokines in alcoholic liver disease.Semin. Liver Dis., 19, 205–219 (1999).
Mitchell, D. and Peterson D. R., Oxidation of aldehydic products of lipid peroxidation by rat liver microsomal aldehyde dehydrogenase.Arch. Biochem. Biophys., 269, 11–17 (1989).
Morgan, E. T., Down-regulation of multiple cytochrome P450 gene products by inflammatory mediatorsin vivo. Independence from the hypothalamo-pituitary axis.Biochem. Pharmacol., 45, 415–419 (1993).
Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C, and Nebert, D. W., P450 superfamily: update on new sequence, gene mapping, accession numbers and nomenclature.Phamacogenetics, 6, 1–42 (1996).
Omura, T. and Sato, R., The carbon monoxide binding pigment of liver microsomes.J. Biol. Chem., 239, 2370–2379 (1964).
Reichen, J., Arts, B., Schafroth, U., Zimmermann, A., Zelter, T. B., and Zysset, T., Aminopyrine N-demethylation by rats with liver cirrhosis.Gastroenterology, 93, 719–726 (1987).
Schenkman, J. B., Remmer, H., and Estabrook, R. W., Spectral studies of drug interaction with hepatic microsomal cytochrome.Mol. Pharmacol., 3, 113–123 (1967).
Selzner, M. and Clavien, P. A., Fatty liver transplantation and surgery.Semin. LiverDis., 21, 105–113 (2001).
Urena, M. A., Ruiz-Delgado, F. C., Gonzalez, E. M., Segurola, C. L, Romero, C. J., Garcia, I. G, Gonzalez-Pinto, I., and Gomez Sanz, R., Assessing risk of the use of livers with macro and microsteatosis in a liver transplant program.Transplant. Proc, 30, 3288–3291 (1998).
Van Thiel, D. H., Makowka, L., and Starzl, T. E., Liver transplantation: where it’s been and where it’s going.Gastroenterol. Clin. North Am., 17, 1–18 (1988).
Yamada, S., Tomiya, T, Yamaguchi, Y., Hiura, M., and Otsuki, M., Activation of hepatic macrophage contributes to hepatic necrosis after post-ischmic reperfusion in alcoholic fatty liver.Hepato. Res., 26, 209–216 (2003).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cho, KH., Lee, SM. Altered activity of cytochrome P450 in alcoholic fatty liver exposed to ischemia/reperfusion. Arch Pharm Res 30, 50–57 (2007). https://doi.org/10.1007/BF02977778
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02977778